Eyebiotech
Eyebiotech
Unlocking Early Success: Choose the Best Biologics!
BIOT
Unlock the secrets to identifying top biologic candidates early! 🚀 Enhance decision-making with innovative strategies and efficient evaluations. 🔍🧬📊
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
BIOT
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market
BIOT
💰 US pharma giant MSD acquires Eyebiotech Ltd for up to $3bn, gaining their clinical pipeline of vision loss candidates. 👁️🗨️🩺 Unanimously approved by EyeBio Board.
